Erbitux
Erbitux Approved for Use With Braftovi for BRAF V600E–Mutated mCRC
The FDA granted approval of a new indication for cetuximab (Erbitux, Lilly) in combination with encorafenib ...
OCTOBER 4, 2021
New Dosing Regimen Approved for Erbitux
The FDA approved a regimen of 500 mg/m2 of cetuximab (Erbitux, ImClone) given intravenously over 120 minutes every ...
APRIL 8, 2021
Load more